Primary Site >> Stomach Cancer

Gene >> PAX3

Journal: Carcinogenesis. 2015 Mar;36(3):390-9.
Title: Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
Author: Zhang, Lin|Xia, Limin|Zhao, Lina|Chen, Zhangqian|Shang, Xin|Xin, Jing|Liu, Muhan|Guo, Xuegang|Wu, Kaichun|Pan, Yanglin|Fan, Daiming
PMID: 25653235
Journal: Oncogenesis. 2015 May 18;4:e149.
Title: The oncogenic role of the cochaperone Sgt1.
Author: Ogi, H|Sakuraba, Y|Kitagawa, R|Xiao, L|Shen, C|Cynthia, M A|Ohta, S|Arnold, M A|Ramirez, N|Houghton, P J|Kitagawa, K
PMID: 25985210
Journal: Oncotarget. 2016 Aug 23;7(34):54744-54757.
Title: PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
Author: Liu, Wei|Sui, Fang|Liu, Jiazhe|Wang, Meichen|Tian, Sijia|Ji, Meiju|Shi, Bingyin|Hou, Peng
PMID: 27458157
Journal: Cancer Biomark. 2018;22(1):111-118.
Title: Serum miR-658 induces metastasis of gastric cancer by activating PAX3-MET pathway: A population-based study.
Author: Wu, Yuanyu|Wan, Xiaoyu|Ji, Fujian|Song, Zheyu|Fang, Xuedong
PMID: 29630524
Journal: Int J Mol Med. 2018 Aug;42(2):713-725.
Title: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review).
Author: Katoh, Masaru
PMID: 29786110